| Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease MG Murer, Q Yan, R Raisman-Vozari Progress in neurobiology 63 (1), 71-124, 2001 | 1122 | 2001 |
| Levodopa in the treatment of Parkinson's disease: current controversies CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonucelli, P Damier, ... Movement disorders 19 (9), 997-1005, 2004 | 507 | 2004 |
| Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease J Salazar, N Mena, S Hunot, A Prigent, D Alvarez-Fischer, M Arredondo, ... Proceedings of the National Academy of Sciences 105 (47), 18578-18583, 2008 | 460 | 2008 |
| Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra K Parain, MG Murer, Q Yan, B Faucheux, Y Agid, E Hirsch, ... Neuroreport 10 (3), 557-561, 1999 | 345 | 1999 |
| Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions MG Murer, G Dziewczapolski, LB Menalled, MC García, Y Agid, ... Annals of Neurology: Official Journal of the American Neurological …, 1998 | 287 | 1998 |
| An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease MG Murer, F Boissiere, Q Yan, S Hunot, J Villares, B Faucheux, Y Agid, ... Neuroscience 88 (4), 1015-1032, 1999 | 229 | 1999 |
| Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological … M Vila, C Perier, J Feger, J Yelnik, B Faucheux, M Ruberg, ... European Journal of Neuroscience 12 (1), 337-344, 2000 | 209 | 2000 |
| Are dopaminergic neurons selectively vulnerable to Parkinson's disease? Y Agid, M Ruberg, F Javoy-Agid, E Hirsch, R Raisman-Vozari, S Vyas, ... Advances in neurology 60, 148-164, 1993 | 199 | 1993 |
| Oxidative stress caused by ozone exposure induces loss of brain repair in the hippocampus of adult rats S Rivas-Arancibia, R Guevara-Guzmán, Y López-Vidal, ... Toxicological Sciences 113 (1), 187-197, 2010 | 196 | 2010 |
| Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon V Blanchard, R Raisman-Vozari, S Vyas, PP Michel, F Javoy-Agid, G Uhl, ... Molecular brain research 22 (1-4), 29-38, 1994 | 171 | 1994 |
| Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules JP Henry, D Botton, C Sagne, MF Isambert, C Desnos, V Blanchard, ... Journal of Experimental Biology 196 (1), 251-262, 1994 | 168 | 1994 |
| Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides D Reglodi, J Renaud, A Tamas, Y Tizabi, SB Socías, E Del-Bel, ... Progress in neurobiology 155, 120-148, 2017 | 162 | 2017 |
| Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways FV Santa-Cecília, B Socias, MO Ouidja, JE Sepulveda-Diaz, L Acuna, ... Neurotoxicity research 29, 447-459, 2016 | 162 | 2016 |
| Molecular Properties and Pharmacokinetic Behavior of Cetirizine, a Zwitterionic H1-Receptor Antagonist A Pagliara, B Testa, PA Carrupt, P Jolliet, C Morin, D Morin, S Urien, ... Journal of medicinal chemistry 41 (6), 853-863, 1998 | 147 | 1998 |
| Single intranasal administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson’s disease RDS Prediger, AS Aguiar, AE Rojas-Mayorquin, CP Figueiredo, ... Neurotoxicity research 17, 114-129, 2010 | 144 | 2010 |
| The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells P Rizk, J Salazar, R Raisman-Vozari, M Marien, M Ruberg, F Colpaert, ... Neuropsychopharmacology 31 (6), 1146-1157, 2006 | 130 | 2006 |
| Levodopa in the treatment of Parkinson's disease: a consensus meeting Y Agid, E Ahlskog, A Albanese, D Calne, T Chase, J De Yebenes, ... Movement disorders 14 (6), 911-913, 1999 | 130 | 1999 |
| Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease D Rial, AA Castro, N Machado, P Garção, FQ Gonçalves, HB Silva, ... PloS one 9 (12), e114216, 2014 | 126 | 2014 |
| Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species F González-Lizárraga, SB Socías, CL Ávila, CM Torres-Bugeau, ... Scientific reports 7 (1), 1-13, 2017 | 120 | 2017 |
| Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption M dos‐Santos‐Pereira, FS Guimaraes, E Del‐Bel, R Raisman‐Vozari, ... Glia 68 (3), 561-573, 2020 | 116 | 2020 |
